FindTrial
Sign In

Diagnostic Performance of Sonazoid Contrast-enhanced Ultrasound for Detection of Hepatocellular Carcinoma

Diagnostic Performance of Sonazoid Contrast-enhanced Ultrasound for Detection of Hepatocellular Carcinoma in Patients with Chronic Liver Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004631
Enrollment
100
Registered
2020-01-16
Start date
2020-01-07
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients with chronic liver disease 2. patients with NHHN>= 1 cm detected on gadoxetic acid-enhanced MRI

Exclusion criteria

Exclusion criteria: 1. patients cannot hold their breath for 3 seconds or longer 2. patients contraindicated to CEUS contrast media 3. patients with hypersensitivity to CEUS contrast media 4. time interval between gadoxetic acid-enhanced MRI and CEUS or CEUS and biopsy/surgery exceeds 1 month 5. NHHNs with poor visibility on ultrasound 6. other patients who are not suitable for the enrollment of this study at the discretion of investigator

Design outcomes

Primary

MeasureTime frame
sensitivity and specificity for the detection of HCC among NHHNs;degree and rate of reperfusion on Kupffer phase—

Secondary

MeasureTime frame
liver stiffness obtained by using shearwave elastography before and after CEUS examination—

Countries

Korea, Republic of

Contacts

Public ContactJae Seok Bae

Seoul National University Hospital

baejae@snu.ac.kr+82-2-2072-3107

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026